BiomX Inc.: A Biotech Pioneer with Pentagon Backing and Significant Market Potential
BiomX Inc. (NYSE: PHGE) stands out in the biotech sector not just for its innovative approach to treating antibiotic-resistant infections but also for its substantial backing from the U.S. Defense Health Agency. With a market capitalization of approximately $13 million, the company has managed to secure $40 million in non-dilutive funding from the Pentagon, a […]